Dean's Diagnosis: 2021 Annual Equity Distribution Implementation Notice
Dean's Diagnosis: Announcement on the 2021 Profit Distribution Plan
Dean's Diagnosis: Announcement on the completion of payment of the first instalment of ultra-short-term financing notes in 2021
Dean's diagnosis: Announcement on the failure to implement the approval for the public issuance of corporate bonds
Dean's Diagnosis: Announcement on the completion of payment of ultra-short-term financing notes
Dian Diagnosis: Announcement on the acquisition of 25% of Dihuixin's shares
Dian Diagnosis: Announcement on the results of the issuance of the first instalment of ultra-short-term financing notes in 2020
Dean's diagnosis: Announcement on sale of shares in Biocore
Dean's Diagnosis: Announcement on the Approval of Registration of Ultra-Short-Term Financing Notes
Dean's Diagnosis: Announcement on the Company's Issuance of Ultra-Short-Term Financing Notes
Dean's Diagnosis: Corporate Bonds Issuance Plan
Dian Diagnosis: Announcement on sale of part of the shares of Zhejiang Bosheng Biotechnology Co., Ltd.
Dian Diagnosis: Announcement on Early Payment and Delisting of “16 Dian 01”
Dian Diagnosis: Beijing Deheng (Hangzhou) Law Firm's Legal Opinion on the Company's “16 Dian 01” First Bondholders' Meeting in 2019
Dian Diagnosis: “16 Dian 01” Announcement of Resolutions of the First Bondholders' Meeting in 2019
Dean's diagnosis: Notice on holding the “16 Dian 01” first bond holders' meeting in 2019
Dean's Diagnosis: Public Issuance of Corporate Bonds to Qualified Investors in 2016 (Phase I) 2019 Interest Payment Announcement
Dian Diagnosis: Announcement on the results of the resale of “16 Dian 01” corporate bonds
Dian Diagnosis: Announcement on the “16 Dian 01” corporate bond resale declaration
Dean\'s diagnosis: Third indicative announcement on the “16 Dian 01” coupon interest rate will not be adjusted and investor resale implementation measures
No Data